Pfizer Inc. (PFE) Operating cash flow 2016–2025
Pfizer Inc. (PFE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$11.7BFY2025 · since FY2016: $16.2B → $11.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.7B | -8.2% |
| FY2024 | $12.7B | +46.5% |
| FY2023 | $8.7B | -70.3% |
| FY2022 | $29.3B | -10.2% |
| FY2021 | $32.6B | +126.2% |
| FY2020 | $14.4B | +14.4% |
| FY2019 | $12.6B | -20.5% |
| FY2018 | $15.8B | -5.8% |
| FY2017 | $16.8B | +3.8% |
| FY2016 | $16.2B | — |
Source: SEC XBRL filings · For reference only · Not investment advice